Latest Genetic testing Stories
Transparency Market Research published a new report "Prenatal and New-born Genetic Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to
ST. PETERSBURG, Fla., May 15, 2014 /PRNewswire-USNewswire/ -- InformedDNA announced today the appointment of Lee Fowinkle as Chief Technology Officer (CTO).
Centralized database of gene-based tests enables easy access to information, improves transparency REDWOOD CITY, Calif., May 14, 2014 /PRNewswire/ -- In response to continued advances
In celebration of National Women's Health Week, InformedDNA is hosting a screening of "Decoding Annie Parker" and expert Q-and-A Session moderated by Charlotte Sutton, the Tampa Bay Times medicine
Mutations in the BRCA1 and BRCA2 genes account for nearly 25 percent of hereditary breast cancers and most hereditary ovarian cancers, yet a study by cancer prevention and control researchers at Virginia Commonwealth University Massey Cancer Center suggests an alarmingly small amount of women who qualify for BRCA genetic counseling actually receive the services.
With expanded screening test, 50 percent of Ashkenazi Jewish individuals are expected to be identified as carriers of at least one of the 38 diseases New York,
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
New opinion piece in Clinical Chemistry analyzes the information provided to consumers from these tests. WASHINGTON, May 5, 2014 /PRNewswire-USNewswire/ -- In November 2013,
Quest Diagnostics' specialty neurology business unveils 10 new epilepsy diagnostic services, including industry's first clinical multi-analyte test for autoimmune epilepsy MADISON,
Fulgent Diagnostics announces a clinical BRCA1/BRCA2 full gene sequencing test for $500. Temple City, California (PRWEB) March 26, 2014 In addition to